
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 54.270 | 54.270 | 0.000 |
Shares | 45.730 | 45.730 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.000 | 19.703 |
Price to Book | 3.534 | 3.888 |
Price to Sales | 1.736 | 2.230 |
Price to Cash Flow | 10.512 | 14.908 |
Dividend Yield | 0.950 | 1.492 |
5 Years Earnings Growth | 13.942 | 10.156 |
Number of long holdings: 19
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Horizon Therapeutics PLC | IE00BQPVQZ61 | 4.80 | - | - | |
Halozyme | US40637H1095 | 4.01 | 59.99 | +1.64% | |
IQVIA Holdings | US46266C1053 | 3.76 | 182.75 | +0.16% | |
Harmony Bio | US4131971040 | 3.72 | 35.54 | +3.31% | |
Jazz Pharma | IE00B4Q5ZN47 | 3.64 | 116.10 | +0.50% | |
Pfizer | US7170811035 | 3.58 | 23.53 | +0.17% | |
HCA | US40412C1018 | 3.58 | 363.20 | +1.75% | |
Centene | US15135B1017 | 3.55 | 26.21 | +1.16% | |
Danaher | US2358511028 | 3.23 | 197.46 | +0.19% | |
BioNTech | US09075V1026 | 2.96 | 110.03 | +2.51% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto CH IPF I Index Equity Fu | 8.11B | -5.69 | 7.90 | 8.97 | ||
Swisscanto CH IPF III Index EquAST | 5.83B | -5.05 | 7.87 | 8.70 | ||
Swisscanto CH IPF I Index Equity CH | 2.66B | -3.79 | 11.90 | 9.45 | ||
CH0296590281 | 2.66B | 1.30 | 9.88 | - | ||
CH0315621927 | 1.79B | 15.21 | -2.36 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review